Novo Nordisk is reportedly searching for obesity experts to staff an R&D centre, Merck Serono gets a new CEO, and we look at the latest biopharmaceutical hires.
WikiLeaks has published a list of overseas biopharmaceutical facilities considered vital to US national security as part of its release of leaked diplomatic cables.
Danish biopharma giant, Novo Nordisk is expanding its R&D Centre in China by introducing a new Diabetes Research unit and doubling its quota of employees from 100 to 200 by 2015.
Packaging group Stralfors says its recent collaboration with Novo Nordisk proves that its service plan is ideal for projects with strict time-to-market requirements.
Despite numerous media reports of an impending patent infringement
suit, Sanofi-Aventis has yet to formally hear anything from
plaintiff Novo Nordisk, who claims the French firm's SoloStar
insulin pen violates patents covering...
Registration is now open for this year's International Society for
Pharmaceutical Engineering (ISPE) European Congress. The topic of
focus is science-based manufacturing for the next decade.
European companies have announced hefty spending on new
manufacturing facilities this month, suggesting that despite a
difficult operating environment the pharmaceutical sector is still
prepared to make significant capital investments